Integrin targeted synthetic ligands for diagnostic and therapeutic applications

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9409951
APP PUB NO 20140178302A1
SERIAL NO

14153706

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel class of diagnostically or therapeutically effective compounds comprising novel aza-bicycloalkane based cyclic peptides, acting as a targeting moiety towards integrin receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRACCO IMAGING S P A20134 MILANO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aime, Silvio Carignano, IT 36 96
Arosio, Daniela Milan, IT 4 5
Delli, Castelli Daniela Bibiana, IT 8 27
Lattuada, Luciano Colleretto Giacosa, IT 55 249
Manzoni, Leonardo Milan, IT 4 5
Morosini, Pierfrancesco Villanova del Sillaro, IT 12 88
Scolastico, Carlo Lerici, IT 26 120
Terreno, Enzo Bibiana, IT 11 33
Uggeri, Fulvio Colleretto Giacosa, IT 62 374

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 9, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00